TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07588568: A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis

Sponsor: University of North Carolina, Chapel Hill · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 52 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$8,300,000

Rescue Site Savings

+$5,478,000

Unlock Full NCT07588568 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07588568 Rescue Dossier →